Skip to main content

Table 3 Comparison of baseline (mean ± SD) and mean (±95% CI) changes for blood related markers

From: Effect of D-ribose supplementation on delayed onset muscle soreness induced by plyometric exercise in college students

Measure

Pre

Change DRIB

Change PLAC

Group p-value

Creatine kinase(U·L− 1)

71.52(12.09)

   

 P 24

 

98.88(− 127.87, −71.90)a

153.74(− 181.98, − 123.28)a

0.002c

 P 48

 

81.21(− 135.65, − 28.77)a

138.17(− 193.11, − 81.02)a

0.079

Lactate Dehydrogenase(U·L− 1)

142.18(50.74)

   

 P 24

 

49.17(−98.68, 5.17)

114.97 (− 172.08, − 63.16)a

0.005c

 P 48

 

34.01(−73.42, 10.21)

162.59(− 209.09, − 121.38)a

< 0.001c

Myoglobin (ng·ml− 1)

46.55(26.85)

   

 P 24

 

50.66(− 113.81, − 55.37)a

86.44(− 54.14, − 15.61)a

0.006c

 P 48

 

16.45(− 124.11, −62.82)a

29.85(−60.99, − 20.58)a

0.230

Superoxide dismutase(U·ml− 1)

48.37(7.57)

   

 P 24

 

11.91(−17.92, − 4.8)a

11.6(− 40.12, − 15.25)a

0.932

 P 48

 

28.23(− 19.09, − 5.32)a

16.66(−30.3, − 4.22)a

0.077

Total antioxidant capacity(U·ml− 1)

3.59(2.19)

   

 P 24

 

21.48(−30.16, − 12.06)a

14.97(−23.49, − 10.48)a

0.157

 P 48

 

17.36(−24.87, − 5.89)a

13.11(− 20.34, − 6.7)a

0.248

Malondialdehyde(U·ml− 1)

4.02(1.39)

   

 P 24

 

1.37(− 3.98, 0.2)

3.75(−1.33, 0.78)a

0.029b

 P 48

 

−0.25(− 5.36, − 0.98)

2.87(− 3.41, − 1.19)a

< 0.001c

  1. DRIB D-ribose group, PLAC Placebo group
  2. a99% CI changes that failed to cross 0 indicates a significant difference vs. Pre
  3. bindicates a significant difference vs. Placebo group (p < 0.05)
  4. cindicates a significant difference vs. Placebo group (p < 0.01)